Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib
Saved in:
| Published in: | Research and Practice in Thrombosis and Haemostasis |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2022
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301671084752899 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Research and Practice in Thrombosis and Haemostasis |
| description | |
| discipline_display | Internal Medicine |
| discipline_facet | Internal Medicine |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:67992 |
| institution | FRELIP |
| journal_source_facet | Research and Practice in Thrombosis and Haemostasis |
| publishDate | 2022 |
| publishDateSort | 2022 |
| record_format | rss_article |
| spellingShingle | Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib Internal Medicine General Internal Medicine |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Internal Medicine General Internal Medicine Internal Medicine General Internal Medicine |
| subject_facet | Internal Medicine General Internal Medicine |
| title | Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib |
| title_auth | Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib |
| title_full | Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib |
| title_fullStr | Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib |
| title_full_unstemmed | Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib |
| title_short | Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib |
| title_sort | platelet caspase‐1 and bruton tyrosine kinase activation in patients with covid‐19 is associated with disease severity and reversed in vitro by ibrutinib |
| topic | Internal Medicine General Internal Medicine |
| url | https://onlinelibrary.wiley.com/doi/10.1002/rth2.12811?af=R |